Richard Essner

11.0k total citations · 3 hit papers
125 papers, 8.0k citations indexed

About

Richard Essner is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Richard Essner has authored 125 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Oncology, 42 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Richard Essner's work include Cutaneous Melanoma Detection and Management (72 papers), Immunotherapy and Immune Responses (39 papers) and Nonmelanoma Skin Cancer Studies (26 papers). Richard Essner is often cited by papers focused on Cutaneous Melanoma Detection and Management (72 papers), Immunotherapy and Immune Responses (39 papers) and Nonmelanoma Skin Cancer Studies (26 papers). Richard Essner collaborates with scholars based in United States, Australia and India. Richard Essner's co-authors include Donald L. Morton, Alistair J. Cochran, Edwin C. Glass, Robert M. Elashoff, Leland J. Foshag, John F. Thompson, Nicola Mozzillo, Daniel F. Roses, Douglas S. Reintgen and Constantine P. Karakousis and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Richard Essner

120 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel-Node Biopsy or Nodal Observation in Melanoma

2006 1.2k citations Donald L. Morton, Richard Essner et al. profile →
Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma

1999 579 citations Donald L. Morton, Richard Essner et al. profile →
Sentinel Node Biopsy for Early-Stage Melanoma

2005 504 citations Donald L. Morton, Richard Essner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Essner United States	47	6.0k	2.4k	2.0k	1.9k	901	125	8.0k
Nicola Mozzillo Italy	30	5.3k 0.9×	2.0k 0.8×	2.0k 1.0×	1.2k 0.6×	649 0.7×	99	6.4k
Marshall M. Urist United States	44	6.3k 1.1×	2.0k 0.8×	2.0k 1.0×	1.4k 0.7×	1.1k 1.2×	100	8.5k
Mark B. Faries United States	42	5.9k 1.0×	1.5k 0.6×	2.6k 1.3×	2.2k 1.1×	689 0.8×	173	7.5k
Raymond L. Barnhill United States	54	7.2k 1.2×	1.9k 0.8×	3.3k 1.7×	1.2k 0.6×	1.3k 1.4×	244	9.7k
Stanley P. L. Leong United States	43	4.4k 0.7×	1.1k 0.5×	2.4k 1.2×	1.1k 0.6×	1.4k 1.6×	221	6.9k
Mohammed Kashani–Sabet United States	47	4.5k 0.8×	1.4k 0.6×	3.9k 2.0×	1.3k 0.7×	935 1.0×	182	7.7k
Mario Santinami Italy	42	5.0k 0.8×	978 0.4×	3.2k 1.6×	2.5k 1.3×	1.2k 1.3×	166	7.9k
Alan Spatz France	45	4.7k 0.8×	863 0.4×	3.4k 1.7×	1.8k 0.9×	1.1k 1.2×	200	7.7k
Constantine P. Karakousis United States	50	6.7k 1.1×	2.4k 1.0×	2.3k 1.2×	936 0.5×	949 1.1×	199	10.1k
Natale Cascinelli Italy	38	8.2k 1.4×	1.9k 0.8×	2.8k 1.4×	2.8k 1.4×	3.5k 3.9×	123	12.1k

Countries citing papers authored by Richard Essner

Since Specialization

Citations

This map shows the geographic impact of Richard Essner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Essner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Essner more than expected).

Fields of papers citing papers by Richard Essner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Essner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Essner. The network helps show where Richard Essner may publish in the future.

Co-authorship network of co-authors of Richard Essner

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Essner. A scholar is included among the top collaborators of Richard Essner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Essner. Richard Essner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lourdault, Kristel, et al.. (2024). Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?. Journal of Surgical Oncology. 131(4). 685–693.

Sibia, Udai S., et al.. (2024). Socially vulnerable patients are more likely to fail outpatient management of symptomatic cholelithiasis. Journal of Gastrointestinal Surgery. 28(7). 1145–1150. 1 indexed citations

Santamaria‐Barria, Juan A., Chikako Matsuba, Adam Khader, et al.. (2023). Age‐related next‐generation sequencing mutational analysis in 1196 melanomas. Journal of Surgical Oncology. 127(7). 1187–1195. 2 indexed citations

Lourdault, Kristel, David Kaufman, KeWei Gong, et al.. (2022). Four Immune Modulating Genes in Primary Melanoma That Predict Metastatic Potential. Journal of Surgical Research. 279. 682–691. 4 indexed citations

Agarwala, Sanjiv S., Merrick I. Ross, Jonathan S. Zager, et al.. (2020). 1125P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Results in patients naïve to immune checkpoint blockade. Annals of Oncology. 31. S756–S756. 3 indexed citations

Zager, Jonathan S., Amod Sarnaik, Shari Pilon‐Thomas, et al.. (2020). 1123P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockade. Annals of Oncology. 31. S755–S756. 4 indexed citations

Huynh, Carissa A., et al.. (2019). Diagnostic utility of dual 5‐hydroxymethylcytosine/Melan‐A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first‐line test for the workup of sentinel lymph node specimen. Journal of Cutaneous Pathology. 46(4). 261–266. 6 indexed citations

Faries, Mark B., Richard Essner, Leland J. Foshag, et al.. (2006). Low lymph flow decreases with age and correlates with non-sentinel node metastases and poor survival in stage III melanoma. Cancer Research. 66. 1119–1119. 1 indexed citations

Essner, Richard, Tarik Belhocine, Andrew M. Scott, & Einat Even‐Sapir. (2006). Novel Imaging Techniques in Melanoma. Surgical Oncology Clinics of North America. 15(2). 253–283. 15 indexed citations

10.

Essner, Richard, Mathew H. Chung, Richard J. Bleicher, et al.. (2002). Prognostic implications of thick (≥4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy. Annals of Surgical Oncology. 9(8). 754–761. 56 indexed citations

11.

Wood, Tabitha E., L. Andrew DiFronzo, David M. Rose, et al.. (2001). Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival?. Annals of Surgical Oncology. 8(8). 658–662. 102 indexed citations

12.

Tsioulias, George J., Rishab K. Gupta, Glenn Tisman, et al.. (2001). Serum TA90 Antigen-Antibody Complex as a Surrogate Marker for the Efficacy of a Polyvalent Allogeneic Whole-Cell Vaccine (CancerVax) in Melanoma. Annals of Surgical Oncology. 8(3). 198–203. 17 indexed citations

13.

Haigh, Philip I., et al.. (1999). Long-Term Survival After Complete Resection of Melanoma Metastatic to the Adrenal Gland. Annals of Surgical Oncology. 6(7). 633–639. 53 indexed citations

14.

Chen, Joseph C.T., Steven O’Day, Donald L. Morton, et al.. (1999). Stereotactic Radiosurgery in the Treatment of Metastatic Disease to the Brain. Stereotactic and Functional Neurosurgery. 73(1-4). 60–63. 20 indexed citations

15.

Ollila, David W., Leland J. Foshag, Richard Essner, Stacey L. Stern, & Donald L. Morton. (1999). Parotid Region Lymphatic Mapping and Sentinel Lymphadenectomy for Cutaneous Melanoma. Annals of Surgical Oncology. 6(2). 150–154. 64 indexed citations

16.

Essner, Richard, Christine Kuo, Hong Wang, et al.. (1998). Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites. Cancer. 82(2). 309–316. 30 indexed citations

17.

Stone, Richard M., Richard Essner, & Arno J. Mundt. (1997). Cancer medicine review. Williams & Wilkins eBooks. 4 indexed citations

18.

Economou, James S., Kristina Rhoades, Richard Essner, et al.. (1989). Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line.. The Journal of Experimental Medicine. 170(1). 321–326. 109 indexed citations

19.

Staren, Edgar D., Richard Essner, & James S. Economou. (1989). Overview of biological response modifiers. Seminars in Surgical Oncology. 5(6). 379–384. 25 indexed citations

20.

Economou, James S., Richard Essner, Kristina Rhoades, et al.. (1988). Molecular mechanisms of interleukin 2 induction of tumor necrosis factor gene expression in macrophages. 39. 426–428. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact